Wegovy maker Novo Nordisk’s chair and six other board members step down

In a surprising turn of events, Helge Lund, the chair of Novo Nordisk, along with six other board members, has announced their resignation following a dispute with a majority shareholder. This shake-up raises concerns about the company's future direction and governance, especially as it comes at a time when Novo Nordisk is under pressure to adapt to shareholder demands for significant changes. The implications of this leadership change could affect the company's strategic decisions and its flagship product, Wegovy, which has been pivotal in its recent success.